APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
David SH Liu, Matthew Read, Carleen Cullinane, Walid J Azar, Christina M Fennell, Karen G Montgomery, Sue Haupt, Ygal Haupt, Klas G Wiman, Cuong P Duong, Nicholas J Clemons, Wayne A Phillips
GUT | BMJ PUBLISHING GROUP | Published : 2015
Awarded by National Health and Medical Research Council (NHMRC) of Australia Centres for Research Excellence grant
This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Centres for Research Excellence grant (1040947) (WAP) and a Peter MacCallum Research Foundation New Investigator grant (DL). DL was supported by the John Loewenthal, Reg Worcester and Eric Bishop Research Fellowships through the Royal Australasian College of Surgeons (RACS) Foundation for Surgery and an Australian Postgraduate Research award from the NHMRC. MR was supported by the Thornell-Shore Memorial scholarship from the RACS and the Sir Thomas Naghten Fitzgerald Scholarship from The University of Melbourne. Some tissue samples used in this project were provided by the Victorian Cancer Biobank with appropriate ethics approval. The Victorian Cancer Biobank is supported by the Victorian Government, Australia.